Download PDF
Am J Perinatol 2022; 39(10): 1097-1103
DOI: 10.1055/s-0040-1721659
Original Article

Zinc Supplementation in Preterm Neonates with Late-Onset Sepsis: Is It Beneficial?

Mohamed Shawky Elfarargy 
1   Faculty of Medicine, Tanta University, Tanta, Egypt
,
Ghada Al-Ashmawy
2   Faculty of Pharmacy, Tanta University, Tanta, Egypt
,
Sally Abu-Risha
2   Faculty of Pharmacy, Tanta University, Tanta, Egypt
,
Haidy Khattab
1   Faculty of Medicine, Tanta University, Tanta, Egypt
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Objective Neonatal sepsis (NS) is a serious neonatal disease. The aim of this study was to detect the role of zinc (Zn) supplementation in preterm neonates with late-onset sepsis (LOS).

Study Design A prospective randomized clinical trial study which was done at Tanta University Hospital from August 2016 to March 2018 on 180 preterm neonates with LOS. The studied neonates were divided into two groups: group 1 (90 neonates), which received Zn and antibiotics, and group 2 (90 neonates), which received antibiotics and placebo. In group 1, the neonates received 1.4 mg elemental Zn/kg/d orally for 10 days. Sepsis score, C-reactive protein (CRP), and procalcitonin (PCT) were done for both groups.

Results As regards sepsis score, it showed that before beginning the treatment, there were 85 and 84 neonates who had high probable sepsis (HPS) in intervention and control groups, respectively, and this revealed nonstatistically significant difference (non-SSD) between both groups (p-value is 0.756) and after 10 days of treatment, there were 1 and 4 neonates who had HPS in intervention and control group, respectively, and this revealed SSD between both groups (p-value is 0.045*). As regards CRP and PCT, the results showed that before beginning the treatment, the mean ± standard deviation (SD) of CRP and PCT were 39.4 ± 10.1 mg/L and 5.2 + 1.8 ng/mL, respectively, in intervention group, while it was 39.6 + 9.9 mg/L and 5.1 + 1.9 ng/mL, respectively, in control group and this revealed non-SSD between both groups (p-value is 0.893 and 0.717, respectively) and after 10 days of treatment, the mean ± SD of CRP and PCT were 5.3 ± 1.8 mg/L and 0.39 ± 0.13 ng/mL, respectively, in intervention group and 6.1 + 2 mg/L and 0.61 + 0.22 ng/mL, respectively, in control group and this revealed SSD between both groups (p-value is 0.008* and 0.044*, respectively).

Conclusion Zn supplementation in preterm neonates with LOS is beneficial in improving the clinical and laboratory finding.

Recommendation Zn supplementation for preterm neonates with LOS.

Key Points

  • NS is a serious neonatal disease.

  • Preterm neonates are more liable to infections.

  • Zn supplementation in preterm neonates with LOS is beneficial in improving the condition.

Keywords

neonate - zinc - sepsis


Publication History

Received: 23 July 2020

Accepted: 02 November 2020

Article published online:
07 December 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Chiesa C, Pacifico L, Natale F, Hofer N, Osborn JF, Resch B. Fetal and early neonatal interleukin-6 response. Cytokine 2013; 76 (01) 1-12
    CrossrefPubMedGoogle Scholar
  • 2 Bloos F, Reinhart K. Rapid diagnosis of sepsis. Virulence 2014; 5 (01) 154-160
    CrossrefPubMedGoogle Scholar
  • 3 Ganesan P, Shanmugam P, Sattar SB, Shankar SL. Evaluation of IL-6, CRP and hs-CRP as early markers of neonatal sepsis. J Clin Diagn Res 2016; 10: DC13e7
    PubMedGoogle Scholar
  • 4 Dong Y, Speer CP. Late-onset neonatal sepsis: recent developments. Arch Dis Child Fetal Neonatal Ed 2015; 100 (03) F257-F263
    CrossrefPubMedGoogle Scholar
  • 5 Sugimoto K, Adomi S, Koike H, Esa A. Procalcitonin as an indicator of urosepsis. Res Rep Urol 2013; 5: 77-80
    PubMedGoogle Scholar
  • 6 Li HX, Liu ZM, Zhao SJ, Zhang D, Wang SJ, Wang YS. Measuring both procalcitonin and C-reactive protein for a diagnosis of sepsis in critically ill patients. J Int Med Res 2014; 42 (04) 1050-1059
    CrossrefPubMedGoogle Scholar
  • 7 van Rossum AM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004; 4 (10) 620-630
    CrossrefPubMedGoogle Scholar
  • 8 Vazzalwar R, Pina-Rodrigues E, Puppala BL, Angst DB, Schweig L. Procalcitonin as a screening test for late-onset sepsis in preterm very low birth weight infants. J Perinatol 2005; 25 (06) 397-402
    CrossrefPubMedGoogle Scholar
  • 9 Esposito S, Principi N. Adjunctive therapy to treat neonatal sepsis. Expert Rev Clin Pharmacol 2020; 13 (01) 65-73
    CrossrefPubMedGoogle Scholar
  • 10 Schüller SS, Kramer BW, Villamor E, Spittler A, Berger A, Levy O. Immunomodulation to prevent or treat neonatal sepsis: past, present, and future. Front Pediatr 2018; 6: 199
    CrossrefPubMedGoogle Scholar
  • 11 Zlotkin SH, Atkinson S, Lockitch G. Trace elements in nutrition for premature infants. Clin Perinatol 1995; 22 (01) 223-240
    CrossrefPubMedGoogle Scholar
  • 12 Loui A, Raab M, Obladen M, Brätter P.. Nutritional zinc balance in extremely low-birth-weight infants. J Pediatr Gastroenterol Nutr 2001; 32 (04) 438-442
    CrossrefPubMedGoogle Scholar
  • 13 Töllner U. Early diagnosis of septicemia in the newborn. Clinical studies and sepsis score. Eur J Pediatr 1982; 138 (04) 331-337
    CrossrefPubMedGoogle Scholar
  • 14 Vergnano S, Buttery J, Cailes B. et al. Brighton Collaboration Neonatal Infections Working Group. Neonatal infections: case definition and guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine 2016; 34 (49) 6038-6046
    CrossrefPubMedGoogle Scholar
  • 15 Terrin G, Berni Canani R, Di Chiara M. et al. Zinc in early life: a key element in the fetus and preterm neonate. Nutrients 2015; 7 (12) 10427-10446
    CrossrefPubMedGoogle Scholar
  • 16 Fowler CL. Procalcitonin for triage of patients with respiratory tract symptoms: a case study in the trial design process for approval of a new diagnostic test for lower respiratory tract infections. Clin Infect Dis 2011; 52 (Suppl. 04) S351-S356
    CrossrefPubMedGoogle Scholar
  • 17 Stojanovic I, Schneider JE, Wei L, Hong Z, Keane C, Schuetz P. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a Chinese hospital system perspective. Clin Chem Lab Med 2017; 55 (04) 561-570
    CrossrefPubMedGoogle Scholar
  • 18 Basnet S, Shrestha PS, Sharma A. et al; Zinc Severe Pneumonia Study Group. A randomized controlled trial of zinc as adjuvant therapy for severe pneumonia in young children. Pediatrics 2012; 129 (04) 701-708
    CrossrefPubMedGoogle Scholar
  • 19 Bhatnagar S, Wadhwa N, Aneja S. et al. Zinc as adjunct treatment in infants aged between 7 and 120 days with probable serious bacterial infection: a randomised, double-blind, placebo-controlled trial. Lancet 2012; 379 (9831): 2072-2078
    CrossrefPubMedGoogle Scholar
  • 20 Sazawal S, Black RE, Menon VP. et al. Zinc supplementation in infants born small for gestational age reduces mortality: a prospective, randomized, controlled trial. Pediatrics 2001; 108 (06) 1280-1286
    CrossrefPubMedGoogle Scholar
  • 21 Terrin G, Berni Canani R, Passariello A. et al. Zinc supplementation reduces morbidity and mortality in very-low-birth-weight preterm neonates: a hospital-based randomized, placebo-controlled trial in an industrialized country. Am J Clin Nutr 2013; 98 (06) 1468-1474
    CrossrefPubMedGoogle Scholar
  • 22 Banupriya N, Bhat BV, Benet BD, Catherine C, Sridhar MG, Parija SC. Short term oral zinc supplementation among babies with neonatal sepsis for reducing mortality and improving outcome - a double-blind randomized controlled trial. Indian J Pediatr 2018; 85 (01) 5-9
    CrossrefPubMedGoogle Scholar
  • 23 Tang Z, Wei Z, Wen F, Wu Y. Efficacy of zinc supplementation for neonatal sepsis: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2019; 32 (07) 1213-1218
    CrossrefPubMedGoogle Scholar
  • 24 Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 1998; 68 (2, Suppl): 447S-463S
    CrossrefPubMedGoogle Scholar
  • 25 Prasad AS. Zinc in human health: effect of zinc on immune cells. Mol Med 2008; 14 (5-6): 353-357
    CrossrefPubMedGoogle Scholar
  • 26 Banupriya N, Vishnu Bhat B, Benet BD, Sridhar MG, Parija SC. Efficacy of zinc supplementation on serum calprotectin, inflammatory cytokines and outcome in neonatal sepsis - a randomized controlled trial. J Matern Fetal Neonatal Med 2017; 30 (13) 1627-1631
    CrossrefPubMedGoogle Scholar
  • 27 Newton B, Bhat BV, Dhas BB, Mondal N, Gopalakrishna SM. Effect of zinc supplementation on early outcome of neonatal sepsis--a randomized controlled trial. Indian J Pediatr 2016; 83 (04) 289-293
    CrossrefPubMedGoogle Scholar
  • 28 Mehta K, Bhatta NK, Majhi S, Shrivastava MK, Singh RR. Oral zinc supplementation for reducing mortality in probable neonatal sepsis: a double blind randomized placebo controlled trial. Indian Pediatr 2013; 50 (04) 390-393
    CrossrefPubMedGoogle Scholar
  • 29 Dramowski A, Madide A, Bekker A. Neonatal nosocomial bloodstream infections at a referral hospital in a middle-income country: burden, pathogens, antimicrobial resistance and mortality. Paediatr Int Child Health 2015; 35 (03) 265-272
    CrossrefPubMedGoogle Scholar
  • 30 Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA. Hospital-acquired neonatal infections in developing countries. Lancet 2005; 365 (9465): 1175-1188
    CrossrefPubMedGoogle Scholar
  • 31 Bizzarro MJ, Shabanova V, Baltimore RS, Dembry LM, Ehrenkranz RA, Gallagher PG. Neonatal sepsis 2004-2013: the rise and fall of coagulase-negative staphylococci. J Pediatr 2015; 166 (05) 1193-1199
    CrossrefPubMedGoogle Scholar
  • 32 Procianoy RS, Silveira RC. The challenges of neonatal sepsis management. J Pediatr (Rio J) 2020; 96 (Suppl. 01) 80-86
    CrossrefPubMedGoogle Scholar